A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery

James C Barrow

doi:10.1021/acsmedchemlett.9b00107

A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery

ACS Med Chem Lett. 2019 Apr 15;10(5):687-689. doi: 10.1021/acsmedchemlett.9b00107. eCollection 2019 May 9.

Author

James C Barrow^{1

2}

Affiliations

¹ Lieber Institute for Brain Development, 855 North Wolfe Street, Baltimore, Maryland 21205, United States.
² Department of Pharmacology, Johns Hopkins University School of Medicine, 855 North Wolfe Street, Baltimore, Maryland 21205, United States.

Abstract

Medicinal chemists have increasing opportunities to transition from the pharmaceutical industry to academic medical centers interested in translational research. This Viewpoint highlights some of the differences between these two cultures and strategies to succeed in academic drug discovery.

Publication types

Editorial